Acute Leukemia — Trials

Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

4,655 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,259
Recruiting: 759
Ph III recruiting: 70
Growth YoY: −1.5%
Industry share: 16%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (720)

clinicaltrialsPublishedShowing 251–300 of 679 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03012672	Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm	completed	Phase 2	50	University of WashingtonOTHER	1	Mar 8, 2022	clinicaltrials
NCT01810705	GRASPA Treatment for Patients With Acute Myeloblastic Leukemia(ENFORCE)	completed	Phase 2	123	ERYtech PharmaINDUSTRY	1	Feb 21, 2022